Table 2.
Proportion of patients with asthma control (ACQ score ≤ 0.75)
| Asthma control |
4 weeks |
12 weeks |
||
|---|---|---|---|---|
| n | % | n | % | |
|
Montelukast monotherapy | ||||
|
All patients, n (%) |
(N = 75) |
(N = 68) |
||
| Well controlled |
46 |
61.3 |
51 |
75.0 |
| Not controlled |
29 |
38.7 |
17 |
25.0 |
|
Preschool aged patients, n (%) |
(N = 34) |
(N =32 ) |
||
| Well controlled |
19 |
55.9 |
24 |
75.0 |
| Not controlled |
15 |
44.1 |
8 |
25.0 |
|
School aged patients, n (%) |
(N =41 ) |
(N = 36) |
||
| Well controlled |
27 |
65.9 |
27 |
75.0 |
| Not controlled |
14 |
34.1 |
9 |
25.0 |
|
Montelukast + ICS | ||||
|
All patients, n (%) |
(N = 244) |
(N = 220) |
||
| Well controlled |
129 |
52.9 |
156 |
70.9 |
| Not controlled |
115 |
47.1 |
64 |
29.1 |
|
Preschool aged patients, n (%) |
(N = 105) |
(N = 96) |
||
| Well controlled |
69 |
65.7 |
75 |
78.1 |
| Not controlled |
36 |
34.3 |
21 |
21.9 |
|
School aged patients, n (%) |
(N = 139) |
(N = 124) |
||
| Well controlled |
60 |
43.2 |
81 |
65.3 |
| Not controlled |
79 |
56.8 |
43 |
34.7 |
|
Total study sample (Montelukast monotherapy & Montelukast + ICS) | ||||
|
All patients, n (%) |
(N = 319) |
(N = 288) |
||
| Well controlled |
175 |
54.9 |
207 |
71.9 |
| Not controlled |
144 |
45.1 |
81 |
28.1 |
|
Preschool aged patients, n (%) |
(N = 139) |
(N = 128) |
||
| Well controlled |
88 |
63.3 |
99 |
77.3 |
| Not controlled |
51 |
36.7 |
29 |
22.7 |
|
School aged patients, n (%) |
(N = 180) |
(N = 160) |
||
| Well controlled |
87 |
48.3 |
108 |
67.5 |
| Not controlled | 93 | 51.7 | 52 | 32.5 |